Kevin Dombkowski

Kevin J. Dombkowski, Dr.PH.

Research Professor, Department of Pediatrics and Communicable Diseases

300 North Ingalls, 6D05
Ann Arbor, MI  48109-5456

Office: (734) 615-6758;  Fax: (734) 232-1400

E-mail: kjd[at]med.umich[dot]edu

Curriculum Vitae

Biography, Education, Projects


Dr. Dombkowski’s research is focused on improving the effectiveness of health services to children, particularly through access to adequate primary care services.  His research includes studies aimed at fostering appropriate preventive services for children with asthma and other chronic conditions, as well as mechanisms to improve the timeliness of childhood vaccinations.  Much of Dr. Dombkowski’s research evaluates improvements to pediatric health services that are enabled through information technology enhancements.

Dr. Dombkowski is active in several collaborations with the Michigan Department of Health and Human Services (MDHHS), including several CDC-funded interventions using the Michigan Care Improvement Registry (MCIR) as well as a wide range of studies related to improving health outcomes among children with chronic conditions such as sickle cell disease, inflammatory bowel disease and asthma.  In addition to his research interests, Dr. Dombkowski has extensive experience with health care information systems, especially immunization registries, public health data management systems and administrative claims data.  Prior to joining the University of Michigan, he served as an information systems consultant to health care systems and public health agencies throughout Michigan and the United States.


DrPH, Public Health Policy, University of Michigan School of Public Health, 2001
M.S., Biometrics, University of Michigan School of Natural Resources, 1983
B.S., Natural Resources, University of Michigan, 1980


Electronic Health Record (EHR) Interoperability with the Michigan Care Improvement Registry (MCIR)

Evaluating Data Quality of Electronic Blood Lead Testing Results

Flint Lead Exposure Registry (FLExR)

Identifying Opportunities to Improve Hydroxyurea Therapy Initiation and Adherence among Children with Sickle Cell Disease‚Äč

QMETRIC Implementation and Quality Improvement